Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid.
about
Interventions for treating cholestasis in pregnancyBile acids and progesterone metabolites in intrahepatic cholestasis of pregnancyBile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatmentObstetric cholestasisReview article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.Review: intrahepatic cholestasis. A puzzling disorder of pregnancy.Safety and tolerability of antiretrovirals during pregnancy.Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women.Antenatal detection of abnormal liver function tests - a marker for poor perinatal outcome.Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasisPruritus in pregnancy: treatment of dermatoses unique to pregnancy.Specific dermatoses of pregnancy and their treatment.Increases in biliary cholesterol-to-bile acid ratio in pregnant hamsters fed low and high levels of cholesterol.Alpha-hydroxybutyrate dehydrogenase activity in intrahepatic cholestasis of pregnancy.Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.Intrahepatic Cholestasis of Pregnancy: Spontaneous FertilizationIntrahepatic cholestasis of pregnancy: Relationship between bile acid levels and maternal and fetal complicationsRandomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy
P2860
Q24201826-5851DF99-7FA7-4992-A801-869865397FE2Q28141896-C79EB362-C668-4930-92C1-00F30D5BA8D6Q28343505-6192C19C-0C8B-487A-AEE1-6FF036EE81F3Q28345286-45BF52CF-B32D-4EC3-837D-6F07B3C10A1CQ33723536-93CB2CE2-2BDC-4B7D-B545-43B1DC2C8F8FQ34740078-3055F63F-B175-4CB9-97F2-BBD0F09AF863Q34981966-562FE81C-AD9A-4896-84E8-2A2BBF864069Q35902730-6F861E1C-D3F3-49BC-8E26-1AB60719BC43Q35931947-47AECA5C-3388-4BAC-BAB4-1366B5FBFDD2Q37186409-052D0B10-F804-4476-BFCB-926DFC1920A8Q37387527-14EBFEE5-47DD-42AE-87BD-7688D9202015Q38126533-8B1C8390-BDDE-42CE-9FD8-D30CC38D9B60Q44279101-1B609C56-A621-4B0F-B7D1-7E2007C8735EQ46512650-531D863F-62ED-4754-9A7F-E0CCC22C4E55Q46946015-D6754C53-AD79-44D0-9DF5-0089DD8F0524Q57127971-ED355375-DD76-4ED9-8742-5C02F6331282Q57150541-24699F28-E506-4A28-A6E3-E3F20A452F36Q57825376-90467B69-25B5-42A9-8C3D-C374E02969B1
P2860
Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid.
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@ast
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@en
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@nl
type
label
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@ast
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@en
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@nl
prefLabel
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@ast
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@en
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@nl
P2093
P2860
P356
P1433
P1476
Fetal mortality associated wit ...... apy with ursodeoxycholic acid.
@en
P2093
P2860
P304
P356
10.1136/GUT.37.4.580
P407
P577
1995-10-01T00:00:00Z